USMLE Step 2 CK practice question: Guillain-Barré syndrome: serial vital capacity monitoring and intravenous immune globulin
USMLE Step 2 CKNervousNeurology
Which of the following is the most appropriate management?
- Pulse oximetry monitoring and high-dose IV methylprednisolone
- Serial vital capacity measurement and IV immune globulin for 5 days
- Arterial blood gases every 12 hours and an oral prednisone taper
- Serial vital capacity measurement and oral pyridostigmine
- Pulse oximetry monitoring and outpatient plasma exchange
Show answer and explanation
Correct answer: B. Serial vital capacity measurement and IV immune globulin for 5 days
Rapidly progressive, symmetric weakness with areflexia after a diarrheal illness (often Campylobacter jejuni) and albuminocytologic dissociation in the CSF (high protein with a normal cell count) indicate Guillain-Barré syndrome (GBS), an immune-mediated polyradiculoneuropathy. About a quarter of patients need mechanical ventilation, and autonomic instability (tachycardia, labile blood pressure, arrhythmias) can be fatal, so patients who cannot walk are admitted to a monitored setting.
Respiratory function is followed with serial forced vital capacity and maximal inspiratory and expiratory pressures, not with pulse oximetry or blood gases, which become abnormal only late, after ventilatory failure is established. A common rule of thumb (20/30/40) prompts elective intubation when FVC falls below 20 mL/kg, maximal inspiratory pressure is weaker than −30 cm H2O, or maximal expiratory pressure is below 40 cm H2O. Disease-modifying treatment for patients unable to walk is IV immune globulin 0.4 g/kg daily for 5 days (ideally within 2 weeks of onset) or plasma exchange (within 4 weeks); they are equally effective, and combining them adds no benefit. Glucocorticoids are ineffective in GBS.
Why the other options are wrong
- A. Pulse oximetry monitoring and high-dose IV methylprednisolone — Oxygen saturation falls late in neuromuscular respiratory failure, and glucocorticoids do not improve outcomes in GBS.
- C. Arterial blood gases every 12 hours and an oral prednisone taper — Blood gases become abnormal only after ventilatory failure develops, and oral glucocorticoids may even delay recovery in GBS.
- D. Serial vital capacity measurement and oral pyridostigmine — Pyridostigmine treats myasthenia gravis, a neuromuscular junction disorder; it does not help a demyelinating polyradiculoneuropathy.
- E. Pulse oximetry monitoring and outpatient plasma exchange — Plasma exchange is effective, but a patient who cannot walk needs inpatient monitoring, and pulse oximetry misses early respiratory decline.
Key point
In Guillain-Barré syndrome, monitor respiratory function with serial vital capacity and treat nonambulatory patients with IVIG or plasma exchange, not glucocorticoids.
Memory hook
GBS: watch the vital capacity, not the oxygen saturation. 20/30/40 means intubate; IVIG or plasma exchange, never steroids.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free